SCHEMBL9924006

SCHEMBL9924006

CC(C)(C)OC(=O)Nc1nc2ccccn2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 2/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
USP7 Q93009 1/20 0.43
RAB9A P51151 7/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
MAPK1 P28482 2/20 0.42
NPC1 O15118 4/20 0.42
KMT2A Q03164 2/20 0.42
GAA P10253 2/20 0.42
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
ABL1 P00519 1/20 0.41
CSF1R P07333 1/20 0.41
RET P07949 1/20 0.41
MET P08581 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923873 0.86 ALDH1A1 (0.48) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL9923908 0.84 ALDH1A1 (0.43) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL30218479 0.84 KMT2A (0.47) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL9923913 0.81 KDM4E (0.43) ALDH1A1KDM4EHPGDHSD17B10RAB9A
SCHEMBL9924019 0.81 KDM4E (0.43) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL22519305 0.80 USP7 (0.41) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL9893288 0.79 RAB9A (0.51) ALDH1A1KDM4EPKMHPGDHSD17B10
SCHEMBL30218471 0.79 MAPK1 (0.61) ALDH1A1KDM4EHPGDHSD17B10RAB9A
SCHEMBL15631825 0.78 TRPA1 (0.42) ALDH1A1KDM4EHPGDUSP7SMN1; SMN2
SCHEMBL9924039 0.73 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
WO-2012078994-A1 IMIDAZO [1, 2-A] PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-06-14 WO disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 ALDH1A1 2230/4885KDM4E 3480/4885PKM 755/4885
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 ALDH1A1 2230/4885KDM4E 3480/4885PKM 755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.